Results 191 to 200 of about 491,626 (323)

Subsequent Primary Hematologic Malignancies in a 21‐Year‐Old Retinoblastoma Survivor: Case Report Study

open access: yesCancer Reports, Volume 8, Issue 12, December 2025.
ABSTRACT Background Retinoblastoma (RB) is a malignant eye tumor that predominantly affects children. Although survival rates have improved significantly due to advancements in treatment, subsequent malignant neoplasms (SMNs) continue to be major causes of death in both heritable and non‐heritable RB cases.
Elham Karimi   +5 more
wiley   +1 more source

Supplementary Figure 1 from MicroRNA-374b Suppresses Proliferation and Promotes Apoptosis in T-cell Lymphoblastic Lymphoma by Repressing AKT1 and Wnt-16

open access: gold, 2023
Qian Dong   +10 more
openalex   +1 more source

CAR‐DC combined with CAR‐T therapy for relapsed/refractory acute myeloid leukaemia: Research progress and future perspectives

open access: yesClinical and Translational Medicine, Volume 15, Issue 12, December 2025.
1. Chimeric antigen receptor T (CAR‐T) therapy has made some progress in the treatment of acute myeloid leukaemia (AML), among which C‐type lectin‐like molecule‐1 (CLL1) CAR‐T‐cell therapy has shown certain efficacy in the treatment of relapsed/refractory (R/R) AML. However, 30% of patients exhibit primary treatment resistance. Key factors limiting the
Rui Zhang   +3 more
wiley   +1 more source

Current status and future directions of T‐lymphoblastic lymphoma in children and adolescents

open access: yesBritish Journal of Haematology, 2016
B. Burkhardt   +3 more
semanticscholar   +1 more source

The Neurocognitive Impact of CAR T Cell Therapy in Hematological Cancers: A Systematic Review of Cognitive Function, Quality of Life, and Psychological Outcomes

open access: yesHealth Science Reports, Volume 8, Issue 12, December 2025.
ABSTRACT Background Chimeric antigen receptor (CAR) T‐cell therapy has revolutionized the treatment of hematological malignancies, offering durable remissions. However, concerns regarding its neurocognitive and psychological impact have emerged, particularly in patients experiencing immune effector cell‐associated neurotoxicity syndrome (ICANS ...
Ashvath Arumugam Pillai   +11 more
wiley   +1 more source

Socioeconomic background and childhood cancer survival in Germany: A nationwide assessment based on data from the German Childhood Cancer Registry

open access: yesInternational Journal of Cancer, Volume 157, Issue 11, Page 2235-2247, 1 December 2025.
What's New? Significant advances in childhood cancer survival have transformed outcomes for many children globally. However, emerging evidence suggests that, even in settings with universal healthcare, these gains are not equally distributed. Here, the authors focused on childhood cancer survival in Germany, using data from the German Childhood Cancer ...
Maike Wellbrock   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy